SERAFINI, MARTA
 Distribuzione geografica
Continente #
EU - Europa 871
NA - Nord America 668
AS - Asia 274
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.814
Nazione #
US - Stati Uniti d'America 660
IT - Italia 249
IE - Irlanda 247
SE - Svezia 138
DE - Germania 110
HK - Hong Kong 56
SG - Singapore 56
CN - Cina 54
UA - Ucraina 54
TR - Turchia 44
IN - India 33
GB - Regno Unito 25
IR - Iran 19
FI - Finlandia 14
CA - Canada 8
FR - Francia 8
BE - Belgio 7
JP - Giappone 7
CZ - Repubblica Ceca 6
AT - Austria 3
ES - Italia 3
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
EU - Europa 1
HU - Ungheria 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
RO - Romania 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 1.814
Città #
Dublin 247
Jacksonville 99
Dearborn 56
Hong Kong 56
Chandler 54
Ann Arbor 44
Singapore 43
Piemonte 39
Wilmington 33
Turin 27
Lawrence 25
Princeton 25
Bremen 23
San Mateo 22
Ankara 20
Munich 16
Ashburn 14
Beijing 14
Zola Predosa 14
Helsinki 13
Vercelli 13
Dallas 12
Kocaeli 11
Novara 11
Milan 10
Hefei 9
Norwalk 8
Andover 7
Brussels 7
Calvisano 7
Santa Clara 7
Seattle 7
Ardabil 6
Brno 6
Toronto 5
Woodbridge 5
Bari 4
Biella 4
Cagliari 4
Fairfield 4
Houston 4
Mülheim 4
Shenyang 4
Zanjan 4
Berlin 3
Boardman 3
Busto Arsizio 3
Cassano Magnago 3
Des Moines 3
Ipswich 3
Monmouth Junction 3
Noicattaro 3
Augusta 2
Barzago 2
Cameriano 2
Chengdu 2
Chongqing 2
Como 2
Falkenstein 2
Genova 2
Grafing 2
Guangzhou 2
Gunzenhausen 2
Jinan 2
Kākināda 2
Leawood 2
Madrid 2
Moncalieri 2
Nanchang 2
Napoli 2
Rankweil 2
San Francisco 2
Torino 2
Trieste 2
Vergiate 2
Wenzhou 2
Aachen 1
Aiello del Sabato 1
Alessandria 1
Altavilla Monferrato 1
Amman 1
Bologna 1
Cambridge 1
Caravaggio 1
Catania 1
Cesano Maderno 1
Chiavari 1
Delhi 1
Emeryville 1
Espoo 1
Finale Emilia 1
Frankfurt am Main 1
Fuzhou 1
Hebei 1
Ho Chi Minh City 1
Horia 1
Huzhou 1
Kecioeren 1
Lissone 1
London 1
Totale 1.143
Nome #
Discovery and development of small molecules targeting IDO1 and SOCE 94
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 90
Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction 88
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 86
Synthesis, biological evaluation and molecular docking of Ugi and Passerini products as novel indoleamine 2,3-dioxygenase 1 inhibitors 84
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 82
A primer of deuterium in drug design 80
A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies 78
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 78
Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors 74
Applications of deuterium in medicinal chemistry 72
The Essential Medicinal Chemistry of Essential Medicines 72
An aryne-based three-component access to α-aroylamino amides 70
SOCE: EMERGE UN NUOVO TARGET TERAPEUTICO DAL “CALCIUM TOOLKIT” DELLA CELLULA 68
A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability 65
Arynes and isocyanides: Two close-knit partners in multicomponent reactions 63
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry 63
The use of 2-hydroxymethyl benzoic acid as an effective water surrogate in the Passerini reaction: A straightforward access to α-hydroxyamides 61
Soft drugs for dermatological applications: recent trends 54
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors 53
The 115 Year Old Multicomponent Bargellini Reaction: Perspectives and New Applications 50
Tritylamine as an ammonia surrogate in the ugi reaction provides access to unprecedented 5-sulfamido oxazoles using burgess-type reagents 49
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs 48
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 48
What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications 45
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy 40
Click 1,2,3-triazoles in drug discovery and development: From the flask to the clinic? 37
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline 36
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 31
Totale 1.859
Categoria #
all - tutte 9.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 0 45 57 14 19 35 33 10
2020/2021196 18 1 18 2 18 18 26 11 35 21 23 5
2021/2022291 27 12 32 41 11 5 13 6 13 47 26 58
2022/2023631 28 29 42 15 61 54 35 37 273 9 35 13
2023/2024202 19 22 21 8 29 3 43 13 6 1 13 24
2024/2025176 12 26 43 16 26 53 0 0 0 0 0 0
Totale 1.859